Literature DB >> 18063222

SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese.

E K Tan1, J Lee, C P Chen, Y Y Teo, Y Zhao, W L Lee.   

Abstract

Genetic variants of the neuronal sortilin-related receptor (SORL1) have been demonstrated to modulate the risk of Alzheimer's disease (AD) in different American and European populations [Rogaeva, E., Meng, Y., Lee, J.H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C.T., Cheng, R., Hasegawa, H., Chen, F., Shibata, N., Lunetta, K.L., Pardossi-Piquard, R., Bohm, C., Wakutani, Y., Cupples, L.A., Cuenco, K.T., Green, R.C., Pinessi, L., Rainero, I., Sorbi, S., Bruni, A., Duara, R., Friedland, R.P., Inzelberg, R., Hampe, W., Bujo, H., Song, Y.Q., Andersen, O.M., Willnow, T.E., Graff-Radford, N., Petersen, R.C., Dickson, D., Der, S.D., Fraser, P.E., Schmitt-Ulms, G., Younkin, S., Mayeux, R., Farrer, L.A., St George-Hyslop, P., 2007. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39 (2), 168-177]. We conducted haloptype analysis involving two genetic clusters of SORL1 in AD and controls among Han Chinese. rs3824968 (SNP 23) was associated with an increased risk of AD, and there was a trend towards association for rs1699102 (SNP 22) and rs2282649 (SNP 24). More robust associations were found for three-loci haplotypes. In particular, the GCA haplotype at SNPs 19-22-23 was associated with an increased risk (odds ratio 1.4), and CTC haplotype at SNPs 19-22-23 and TCT at SNPs 22-23-24 a decreased risk (odds ratio 0.67) of AD. The complete absence of some at-risk North European haplotypes in our Chinese study subjects was likely due to different ancestral origins, with allelic heterogeneity among races. However, our study suggests that certain SORL1 haplotypes at SNPs 19-24 modulated risk of AD in our Chinese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063222     DOI: 10.1016/j.neurobiolaging.2007.10.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  43 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  The Alzheimer's associated 5' region of the SORL1 gene cis regulates SORL1 transcripts expression.

Authors:  Jeanette J McCarthy; Sunita Saith; Colton Linnertz; James R Burke; Christine M Hulette; Kathleen A Welsh-Bohmer; Ornit Chiba-Falek
Journal:  Neurobiol Aging       Date:  2010-12-23       Impact factor: 4.673

3.  No association of psychosis in Alzheimer disease with neurodegenerative pathway genes.

Authors:  Mary Ann A DeMichele-Sweet; Lambertus Klei; Bernie Devlin; Robert E Ferrell; Elise A Weamer; James E Emanuel; Oscar L Lopez; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2010-11-18       Impact factor: 4.673

Review 4.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

Review 5.  The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review.

Authors:  Christiane Reitz
Journal:  Mol Genet Genomics       Date:  2014-10-21       Impact factor: 3.291

6.  SORL1 rs1699102 polymorphism modulates age-related cognitive decline and gray matter volume reduction in non-demented individuals.

Authors:  He Li; Chenlong Lv; Caishui Yang; Dongfeng Wei; Kewei Chen; Shaowu Li; Zhanjun Zhang
Journal:  Eur J Neurol       Date:  2016-10-25       Impact factor: 6.089

Review 7.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

8.  No association of SORL1 SNPs with Alzheimer's disease.

Authors:  Ryan L Minster; Steven T DeKosky; M Ilyas Kamboh
Journal:  Neurosci Lett       Date:  2008-05-27       Impact factor: 3.046

Review 9.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

10.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain.

Authors:  Karrie E Grear; I-Fang Ling; James F Simpson; Jennifer L Furman; Christopher R Simmons; Shawn L Peterson; Frederick A Schmitt; William R Markesbery; Qiang Liu; Julia E Crook; Steven G Younkin; Guojun Bu; Steven Estus
Journal:  Mol Neurodegener       Date:  2009-11-04       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.